MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BIO — Bio-Rad Laboratories, Inc.Class A

NYSE

Bio-Rad Laboratories, Inc.Class A

CompareBack to Screener
$369.14
+13.57(+3.82%)
O
357.28
H
369.40
L
357.28
V
223.64K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Bio-Rad Laboratories, Inc.Class A Statistics

Total Valuation

Market Cap$10.19B
Enterprise Value$10.23B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding21.68M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio11.68
P/TBV Ration/a
P/FCF Ratio130.44
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-194.09
EV / Salesn/a
EV / EBITDA105.80
EV / EBIT-151.01
EV / FCF130.99

Financial Position

Current Ratio3.21
Quick Ration/a
Debt / Equity0.14
Debt / EBITDA0.97
Debt / FCF1.21
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-7.69%
Return on Assets (ROA)-5.38%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-7,075
Employee Count7,450
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax-$16.27M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+25.46%
50-Day Moving Average$365.64
200-Day Moving Average$307.72
Relative Strength Index (RSI)50.36
Average Volume (20 Days)272,704

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$30.94M
Operating Income$34.10M
Pretax Income-$68.98M
Net Income-$52.71M
EBITDA$96.70M
EBIT-$67.75M
Loss Per Share$-19.55

Balance Sheet

Cash & Cash Equivalents$50.72M
Total Debt$94.15M
Net Cash-$43.43M
Net Cash Per Share$-2.00
Equity (Book Value)$685.13M
Book Value Per Share$31.61
Working Capital$202.51M

Cash Flow

Operating Cash Flow-$61.99M
Capital Expenditures-$29.90M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$78.10M
FCF Per Share$3.60

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield0.77%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a